Journal articles on the topic 'Pharmaceutical industry – Germany'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Pharmaceutical industry – Germany.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
SALIKHOVA, Olena, and Daria HONCHARENKO. "DEVELOPMENT POLICY OF THE PHARMACEUTICAL INDUSTRY IN GERMANY: LESSONS FOR UKRAINE." Economy of Ukraine 2020, no. 10 (October 25, 2020): 63–86. http://dx.doi.org/10.15407/economyukr.2020.10.063.
Full textSchmidt, Axel, Dirk Köster, and Jochen Strube. "Climate Neutrality Concepts for the German Chemical–Pharmaceutical Industry." Processes 10, no. 3 (February 25, 2022): 467. http://dx.doi.org/10.3390/pr10030467.
Full textWulf, Stefan. "The Revista Médica project: medical journals as instruments of German foreign cultural policy towards Latin America, 1920-1938." História, Ciências, Saúde-Manguinhos 20, no. 1 (March 2013): 181–201. http://dx.doi.org/10.1590/s0104-59702013000100010.
Full textHoncharenko, D. O. "The Pharmaceutical Industry in New EU Member States: A Statistical Comparison with Germany. Lessons for Ukraine." Statistics of Ukraine 92, no. 2 (June 15, 2021): 26–38. http://dx.doi.org/10.31767/su.2(93)2021.02.03.
Full textUhl, Alexander, Axel Schmidt, Christoph Jensch, Dirk Köster, and Jochen Strube. "Development of Concepts for a Climate-Neutral Chemical–Pharmaceutical Industry in 2045." Processes 10, no. 7 (June 30, 2022): 1289. http://dx.doi.org/10.3390/pr10071289.
Full textSchosser, R. "Risk/Benefit Evaluation of Drugs: The Role of the Pharmaceutical Industry in Germany." European Surgical Research 34, no. 1-2 (2002): 203–7. http://dx.doi.org/10.1159/000048910.
Full textVitols, Sigurt. "Shareholder Value, Management Culture and Production Regimes in the Transformation of the German Chemical-Pharmaceutical Industry." Competition & Change 6, no. 3 (September 2002): 309–25. http://dx.doi.org/10.1080/10245290215047.
Full textTheiselmann, Rüediger. "Aussenwirtschaftsrecht and corporate investments in Germany – new hurdles for foreign investors." German Law Journal 10, no. 11 (November 1, 2009): 1495–503. http://dx.doi.org/10.1017/s2071832200018344.
Full textDubois, Pierre, and Laura Lasio. "Identifying Industry Margins with Price Constraints: Structural Estimation on Pharmaceuticals." American Economic Review 108, no. 12 (December 1, 2018): 3685–724. http://dx.doi.org/10.1257/aer.20140202.
Full textBruchhausen, Walter. "Between Foreign Politics and Humanitarian Neutrality: Medical Emergency Aid by the Two German States before 1970." Social History of Medicine 32, no. 4 (April 9, 2018): 819–42. http://dx.doi.org/10.1093/shm/hky019.
Full textSchmäl, Christine, Katja Becker, Ruth Berg, Michael Brünger, Gerd Lehmkuhl, Klaus-Ulrich Oehler, Thorsten Ruppert, Claus Staudter, Götz-Erik Trott, and Ralf W. Dittmann. "Pediatric Psychopharmacological Research in the Post EU Regulation 1901/2006 Era." Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 42, no. 6 (January 1, 2014): 441–49. http://dx.doi.org/10.1024/1422-4917/a000322.
Full textSchmidt, Axel, Lukas Uhlenbrock, and Jochen Strube. "Technical Potential for Energy and GWP Reduction in Chemical–Pharmaceutical Industry in Germany and EU—Focused on Biologics and Botanicals Manufacturing." Processes 8, no. 7 (July 11, 2020): 818. http://dx.doi.org/10.3390/pr8070818.
Full textHöfer-Bosse, T., and W. Scharmann. "Numbers of Animals Used in Toxicological Experiments—With Particular Reference to the Federal Republic of Germany." Alternatives to Laboratory Animals 13, no. 3 (March 1985): 212–19. http://dx.doi.org/10.1177/026119298501300309.
Full textHoncharenko, D. О. "New ApproacheThe pharmaceutical industry’s R&D expenditure at the global level in 2007–2018 is analyzed. Two-thirds of the global pharmaceutical companies’ spending on R&D are accounted for s to the Assessment of Foreign Trade in High-Tech Pharmaceuticals." Statistics of Ukraine 88, no. 1 (May 1, 2020): 35–41. http://dx.doi.org/10.31767/su.1(88)2020.01.04.
Full textL., J. F. "ATTITUDES TO RANDOMIZED TRIALS (1970S)." Pediatrics 93, no. 6 (June 1, 1994): A44. http://dx.doi.org/10.1542/peds.93.6.a44.
Full textFESTEL, GUNTER. "SIMILARITIES OF SUCCESSFUL TECHNOLOGY TRANSFER THROUGH NEW VENTURES." International Journal of Innovation Management 19, no. 02 (April 2015): 1550025. http://dx.doi.org/10.1142/s1363919615500255.
Full textLiebenau, Jonathan. "Ethical Business: The Formation of the Pharmaceutical Industry in Britain, Germany, and the United States Before 1914." Business History 30, no. 1 (January 1988): 116–29. http://dx.doi.org/10.1080/00076798800000007.
Full textHolzmann-Littig, Christopher, Matthias Braunisch, Peter Kranke, Maria Popp, Christian Seeber, Falk Fichtner, Bianca Littig, et al. "COVID-19 Vaccination Acceptance and Hesitancy among Healthcare Workers in Germany." Vaccines 9, no. 7 (July 12, 2021): 777. http://dx.doi.org/10.3390/vaccines9070777.
Full textToktonalieva, N., and I. Toktonaliev. "History and Background of the Implementation of Good Manufacturing Practice Standards in the Pharmaceutical Industry (Review)." Bulletin of Science and Practice 6, no. 9 (September 15, 2020): 182–91. http://dx.doi.org/10.33619/2414-2948/58/17.
Full textMahajan, Varun. "Structural changes and trade competitiveness in the Indian pharmaceutical industry in product patent regime." International Journal of Pharmaceutical and Healthcare Marketing 13, no. 1 (April 1, 2019): 21–39. http://dx.doi.org/10.1108/ijphm-12-2016-0066.
Full textAnton, V., K. Gehrke, and F. P. Hessel. "The Relevance of Health Services Research for the Pharmaceutical Industry in Germany –Results of A Representative Online Survey." Value in Health 17, no. 7 (November 2014): A414. http://dx.doi.org/10.1016/j.jval.2014.08.995.
Full textWeihrauch, Thomas R., and Eberhard Baumbauer. "ChemInform Abstract: Clinical Drug Research in Germany - Problems and Chances - From the Pharmaceutical Industry′s Point of View." ChemInform 30, no. 9 (June 17, 2010): no. http://dx.doi.org/10.1002/chin.199909283.
Full textHering, Stefanie, Nico Schäuble, Thomas M. Buck, Brigitta Loretz, Thomas Rillmann, Frank Stieneker, and Claus-Michael Lehr. "Analysis and Optimization of Two Film-Coated Tablet Production Processes by Computer Simulation: A Case Study." Processes 9, no. 1 (December 30, 2020): 67. http://dx.doi.org/10.3390/pr9010067.
Full textChase, D. P., and V. E. Amelung. "PHP25 The Pharmaceutical Industry as Partner in Integrated Care Contracts - Potential Improvement or Vain Attempt? First Experiences from Germany." Value in Health 15, no. 7 (November 2012): A293. http://dx.doi.org/10.1016/j.jval.2012.08.567.
Full textTarasenko, V. A., T. V. Prykhodko, О. F. Кuchmistova, A. M. Solomenniy, O. V. Pleshkova, O. V. Belozerova, and D. V. Drozdov. "PHARMACEUTICALS MARKETING RESEARCHES FOR USE IN DERMATOLOGY AND ON THE PHARMACEUTICAL MARKET OF UKRAINE IN GENERAL (MESSAGE I)." Fitoterapia 3, no. 3 (2021): 67–74. http://dx.doi.org/10.33617/2522-9680-2021-3-67.
Full textHollo, Anna-Lena. "Die Rolle des Staates bei der Entwicklung von Arzneimitteln und Impfstoffen." Die Verwaltung 54, no. 3 (July 1, 2021): 375–410. http://dx.doi.org/10.3790/verw.54.3.375.
Full textStoll, Marlene, Lara Hubenschmid, Cora Koch, and Klaus Lieb. "Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016." BMJ Open 10, no. 9 (September 2020): e037395. http://dx.doi.org/10.1136/bmjopen-2020-037395.
Full textSCHÜTTE, TINO. "INVESTMENT ADJUSTMENTS IN PRODUCT MARKET COMPETITION." International Journal of Innovation and Technology Management 10, no. 05 (October 2013): 1340017. http://dx.doi.org/10.1142/s0219877013400178.
Full textKashyntseva, Oksana, and Yaroslav Iolkin. "Ukrainian experience in implementation of the flexible provisions of the TRIPS Agreement in the context of European integration and the pandemic." Theory and Practice of Intellectual Property, no. 5 (November 17, 2021): 140–45. http://dx.doi.org/10.33731/52021.244533.
Full textBrittain, Harry G. "Book Review ofPolymorphism in the Pharmaceutical IndustryPolymorphism in the Pharmaceutical Industry . Edited by Rolf Hilfiker . Wiley-VCH Verlag GmbH & Co. Weinheim, Germany . 2006 . $215. 978-3-527-31146-0 ." Crystal Growth & Design 8, no. 7 (July 2008): 2588. http://dx.doi.org/10.1021/cg800538r.
Full textLazorenko, Valeriia, Liudmyla Saher, and Adam Jasnikowski. "Web management as a marketing management determinant: case for pharmaceutical enterprises." Health Economics and Management Review 2, no. 2 (2021): 105–14. http://dx.doi.org/10.21272/hem.2021.2-10.
Full textKaffai, Marius, and Raphael H. Heiberger. "Modeling non-pharmaceutical interventions in the COVID-19 pandemic with survey-based simulations." PLOS ONE 16, no. 10 (October 28, 2021): e0259108. http://dx.doi.org/10.1371/journal.pone.0259108.
Full textDintsios, C., and S. Schlenkrich. "Pharmaceutical Industry\X92S Experiences With The Scientific Advice Offered By The Federal Joint Committee Within The Early Benefit Assessment Of Drugs In Germany." Value in Health 19, no. 7 (November 2016): A450. http://dx.doi.org/10.1016/j.jval.2016.09.598.
Full textBechoux, Lucas, Oriane De Vleeschouwer, Cécile Vanheuverzwijn, Florence Verhegghen, Alizée Detiffe, Fabian Colle, Catherine Fallon, and François Thoreau. "Conflict of interest policies at Belgian medical faculties: Cross-sectional study indicates little oversight." PLOS ONE 16, no. 2 (February 10, 2021): e0245736. http://dx.doi.org/10.1371/journal.pone.0245736.
Full textGötze, Stefanie, Debora Jeske, and Karolina Benters. "Training challenges in regulated industries: making it work." Strategic HR Review 17, no. 3 (June 11, 2018): 155–59. http://dx.doi.org/10.1108/shr-12-2017-0089.
Full textSchreuder, Y. "The German-American Pharmaceutical Business Establishment in the New York Metropolitan Region." Environment and Planning A: Economy and Space 30, no. 10 (October 1998): 1743–56. http://dx.doi.org/10.1068/a301743.
Full textEandi, Mario, and Carlo Della Pepa. "I farmaci “generici” in Italia: opportunità di ricerca e sviluppo di prodotti di qualità a prezzi competitivi." Farmeconomia. Health economics and therapeutic pathways 4, no. 2 (June 15, 2003): 65–76. http://dx.doi.org/10.7175/fe.v4i2.770.
Full textMohammad, Al Sayasneh, O. A. Ruban, I. V. Kovalevska, and O. M. Ievtushenko. "Аnalysis of the market of medicinal products for the conservative treatment of hemorrhoids in order to determine the marketing opportunities for a domestic manufacturer." Social Pharmacy in Health Care 8, no. 4 (December 19, 2022): 46–58. http://dx.doi.org/10.24959/sphhcj.22.274.
Full textKang, Moon Young. "What Makes Companies to Survive over a Century? The Case of Dongwha Pharmaceutical in the Republic of Korea." Sustainability 14, no. 2 (January 14, 2022): 946. http://dx.doi.org/10.3390/su14020946.
Full textCornago, Dante, and Livio Garattini. "Il mercato dei dispositivi per stomia in cinque paesi europei: lezioni per l’Italia." Farmeconomia. Health economics and therapeutic pathways 2, no. 2 (June 15, 2001): 115–23. http://dx.doi.org/10.7175/fe.v2i2.724.
Full textFarahani, I., A. Laven, S. Farahani, MA Deters, M. Feickert, FK Suessenbach, H. Schwender, and S. Laeer. "P33 Effectiveness of OSCEs in training German pharmacy students in consultation on self-medication – a randomised controlled investigation." Archives of Disease in Childhood 104, no. 6 (May 17, 2019): e30.2-e31. http://dx.doi.org/10.1136/archdischild-2019-esdppp.71.
Full textUliasz-Misiak, Barbara. "Water Accompanying Hydrocarbon Deposits as a Potential Source of Iodine, Lithium and Strontium." Gospodarka Surowcami Mineralnymi 32, no. 2 (June 1, 2016): 31–44. http://dx.doi.org/10.1515/gospo-2016-0012.
Full textKrstić, Đurđa, Petar Ristivojević, Filip Andrić, Dušanka Milojković-Opsenica, and Gertrud E. Morlock. "Quality Assessment of Apple and Grape Juices from Serbian and German Markets by Planar Chromatography—Chemometrics." Molecules 27, no. 12 (June 19, 2022): 3933. http://dx.doi.org/10.3390/molecules27123933.
Full textGeraats, B., M. Parnowska, and L. Kox. "Future proof decentralised sludge recycling Elodry-pro®." Water Practice and Technology 15, no. 3 (December 8, 2016): 840–48. http://dx.doi.org/10.2166/wpt.2017.018.
Full textMonleon, Clara, Mondher Toumi, Hans-Martin Späth, Claude Dussart, and Carlos Crespo. "PP114 The Influence Of Implicit Factors On The Health Technology Assessment Deliberative Process: A Survey In Five European Countries." International Journal of Technology Assessment in Health Care 38, S1 (December 2022): S78. http://dx.doi.org/10.1017/s0266462322002379.
Full textBlackett, Tom. "Branding and the Rise of the Generic Drug." Marketing Intelligence & Planning 10, no. 9 (September 1, 1992): 21–24. http://dx.doi.org/10.1108/02634509210020097.
Full textKuhach, V. V. "PHARMACY MANUFACTURE AND QUALITY CONTROL OF MEDICINAL PREPARATIONS ABROAD." Vestnik Farmacii 92, no. 2 (June 30, 2021): 64–79. http://dx.doi.org/10.52540/2074-9457.2021.2.64.
Full textYoshimori, Masaru. "The German Healthcare System and Pharmaceutical Industry." Iryo To Shakai 12, no. 2 (2002): 21–48. http://dx.doi.org/10.4091/iken1991.12.2_21.
Full textAndryushayev, Oleksiy, Olena Ruban, Yuliia Maslii, and Inna Rusak. "Intensification of the extraction process of phenolic compounds from Acorus calamus leaves." ScienceRise: Pharmaceutical Science, no. 4(32) (August 31, 2021): 4–10. http://dx.doi.org/10.15587/2519-4852.2021.238329.
Full textBENNETT, G. "Peter Bamfield, Research and Development in the Chemical and Pharmaceutical Industry (3rd ed.), Wiley–VCH Verlag GmbH & Co., Weinheim, Germany (2006) 288 pp., Price: US$ 100.00, ISBN: 3-527-31775-9." Journal of Hazardous Materials 145, no. 3 (July 16, 2007): 521. http://dx.doi.org/10.1016/j.jhazmat.2007.02.065.
Full text